Rapid Therapeutic Science Laboratories, Inc. (RTSL) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
558 COUNTY ROAD 472 DE LEON, TX 76444 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)
| 6/30/2023 MRQ | 12/31/2022 | 12/31/2021 | 3/31/2020 | 3/31/2019 | 3/31/2018 | 3/31/2017 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 192,484 | 136,215 | 1,334 | 12,297 | 7,395 | ||||
| Cash and cash equivalents | 192,484 | 136,215 | 1,334 | 12,297 | 7,395 | ||||
| Receivables | |||||||||
| Inventory, net of allowances, customer advances and progress billings | 175,047 | 175,047 | 5,873 | ||||||
| Inventory | 175,047 | 175,047 | 5,873 | ||||||
| Prepaid expense | 58,146 | 51,631 | 10,184 | ||||||
| Total current assets: | 233,193 | 419,162 | 142,088 | 1,334 | 22,481 | 7,395 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 340,136 | 425,171 | ✕ | ✕ | ✕ | ||||
| Property, plant and equipment | 1,511,176 | 1,185,562 | |||||||
| Intangible assets, net (including goodwill) | 170,075 | 170,075 | 302,500 | 3,761 | |||||
| Intangible assets, net (excluding goodwill) | 170,075 | 170,075 | 302,500 | 3,761 | |||||
| Total noncurrent assets: | 2,021,387 | 1,780,808 | 302,500 | 3,761 | |||||
| TOTAL ASSETS: | 2,254,580 | 2,199,970 | 444,588 | 1,334 | 26,242 | 7,395 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 124,736 | 45,696 | 465,297 | 228,792 | 40,159 | 300 | |||
| Interest and dividends payable | ✕ | ✕ | 45,696 | 400,720 | 209,140 | 28,609 | |||
| Accounts payable | 64,577 | 19,652 | 11,550 | 300 | |||||
| Accrued liabilities | 124,736 | ||||||||
| Debt | 820,602 | 1,099,734 | 883,185 | ||||||
| Derivative instruments and hedges, liabilities | 508,593 | 1,085,360 | 32,000 | ||||||
| Due to related parties | 283,700 | 23,350 | 741,035 | 3,400 | 30,000 | ||||
| Other undisclosed current liabilities | 3,511,897 | 538,493 | 90,000 | 645,335 | |||||
| Total current liabilities: | 4,965,828 | 3,052,983 | 1,493,832 | 969,827 | 688,894 | 30,300 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 378,744 | 315,240 | 2,200,000 | 2,200,000 | |||||
| Long-term debt, excluding current maturities | 315,240 | 2,200,000 | 2,200,000 | ||||||
| Liabilities, other than long-term debt | 280,235 | ||||||||
| Operating lease, liability | 280,235 | 378,744 | ✕ | ✕ | ✕ | ||||
| Other undisclosed noncurrent liabilities | 150,000 | (228,744) | |||||||
| Total noncurrent liabilities: | 430,235 | 528,744 | 315,240 | 2,200,000 | 2,200,000 | ||||
| Total liabilities: | 5,396,063 | 3,581,727 | 1,809,072 | 3,169,827 | 2,888,894 | 30,300 | |||
| Equity | |||||||||
| Equity, attributable to parent | (3,141,483) | (1,381,757) | (1,364,484) | (3,168,493) | (2,862,652) | (22,905) | |||
| Common stock | 7,763 | 193,567 | 159,556 | 1,204 | 1,204 | 2,710 | |||
| Treasury stock, value | (337,339) | (337,339) | (337,339) | (337,339) | (337,339) | ||||
| Additional paid in capital | 7,504,242 | 7,283,438 | 2,414,718 | 144,477 | 101,477 | 49,465 | |||
| Accumulated deficit | (10,316,149) | (8,521,423) | (3,601,419) | (2,976,835) | (2,627,994) | (75,080) | |||
| Total equity: | (3,141,483) | (1,381,757) | (1,364,484) | (3,168,493) | (2,862,652) | (22,905) | |||
| TOTAL LIABILITIES AND EQUITY: | 2,254,580 | 2,199,970 | 444,588 | 1,334 | 26,242 | 7,395 | |||
Income Statement (P&L) (USD)
| 6/30/2023 TTM | 12/31/2022 | 12/31/2021 | 3/31/2020 | 3/31/2019 | 3/31/2018 | 3/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 534 | 9,139 | 1,380 | |||||
| Gain on disposition of assets for financial service operations | 1,380 | ✕ | ✕ | |||||
| Cost of revenue (Cost of Goods and Services Sold) | (200) | (7,155) | ||||||
| Gross profit: | 334 | 1,984 | 1,380 | |||||
| Operating expenses | (2,502,694) | (4,285,399) | (832,474) | (339,380) | (287,757) | (21,616) | ||
| Operating loss: | (2,502,694) | (4,285,065) | (830,490) | (338,000) | (287,757) | (21,616) | ||
| Nonoperating income (expense) | (531,393) | (697,588) | (191,581) | (179,151) | (2,400,839) | |||
| Interest and debt expense | (1,895,650) | (1,329,441) | (191,581) | (180,531) | (28,609) | |||
| Loss from continuing operations before equity method investments, income taxes: | (4,929,737) | (6,312,094) | (1,213,652) | (697,682) | (2,717,205) | (21,616) | ||
| Other undisclosed income from continuing operations before income taxes | 3,135,011 | 3,444,211 | ||||||
| Income (loss) from continuing operations: | (1,794,726) | (2,867,883) | (1,213,652) | (697,682) | (2,717,205) | (21,616) | ||
| Loss before gain (loss) on sale of properties: | ✕ | (2,867,883) | (1,213,652) | (697,682) | (2,717,205) | (21,616) | ||
| Net income (loss): | (1,794,726) | (2,867,883) | (1,213,652) | (697,682) | (2,717,205) | (21,616) | ||
| Other undisclosed net income attributable to parent | 589,068 | 348,841 | 164,291 | |||||
| Net income (loss) available to common stockholders, diluted: | (1,794,726) | (2,867,883) | (624,584) | (348,841) | (2,552,914) | (21,616) | ||
Comprehensive Income (USD)
| 6/30/2023 TTM | 12/31/2022 | 12/31/2021 | 3/31/2020 | 3/31/2019 | 3/31/2018 | 3/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (1,794,726) | (2,867,883) | (1,213,652) | (697,682) | (2,717,205) | (21,616) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (1,794,726) | (2,867,883) | (1,213,652) | (697,682) | (2,717,205) | (21,616) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.